DTaP-Hib (Yunnan Walvax Biotech)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDTaP-Hib (Yunnan Walvax Biotech)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Combination vaccineVaccines > Biological material > Toxoid vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsTetanusDiphtheriaHaemophilus Infections +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaPending

Originator CompaniesWalvax Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesWalvax Biotechnology Co Ltd

Active IndicationsN/A

Inactive IndicationsTetanusDiphtheriaHaemophilus Infections +[4]

Other Information

ATC CodeN/A